Drug lookup
Drug reference

Paracetamol + Caffeine + Phenylephrine

NSAID · Cold and Flu Medication, Symptomatic Relief of Common Cold

Also known as Crocin Cold & Flu, Dolo Cold, Sumo Cold, FluCip, Sinarest, Vicks Action 500 Advance

NSAIDCold and Flu Medication, Symptomatic Relief of Common Cold
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
12 major
incl. contraindicated
PREGNANCY
Category C (Phenylephrine is Category C; Paracetamol is Category B; Caffeine is Category B or C depending on dose and source). Overall, the combination is generally considered Category C due to Phenylephrine. Use only if the potential benefit justifies the potential risk to the fetus.
FDA category + note
Top interactionssee all 12
  • SulfasalazineContraindicatedTextbookG&G 14e · p1112
  • AminoglycosideSevereTextbookKDT 7e · p746
  • AminoglycosidesSevereTextbookKDT 7e
  • AnticoagulantsSevereTextbookKDT 7e

Mechanism

Paracetamol exerts its analgesic and antipyretic effects primarily by inhibiting prostaglandin synthesis in the central nervous system. Caffeine acts as a central nervous system stimulant, enhancing the analgesic effect of paracetamol and counteracting the potential for sedation. Phenylephrine, an alpha-1 adrenergic agonist, causes vasoconstriction in the nasal mucosa, thereby reducing swelling and congestion. Combination rationale: This FDC combines a non-opioid analgesic and antipyretic (Paracetamol) with a central nervous system stimulant (Caffeine) to enhance the analgesic effect and counteract potential sedation, and a decongestant (Phenylephrine) to relieve nasal congestion. This combination provides comprehensive symptomatic relief for multiple common cold and flu symptoms such as fever, pain, and stuffy nose, improving patient convenience and compliance.

Indications

Symptomatic relief of nasal congestionFeverHeadacheBody acheSinusitis associated with common cold or fluAllergic rhinitis

Dosing

Adult
Oral: Typically 1 tablet containing Paracetamol 325-500 mg, Caffeine 25-30 mg, and Phenylephrine 5-10 mg, 3-4 times a day as needed. Do not exceed 4 doses in 24 hours.
Pediatric
Not recommended for children under 6 years. For children 6-12 years, consult a physician for age- and weight-appropriate dosing; specific pediatric formulations with lower strengths may be available. Generally, half the adult dose, not exceeding 4 doses in 24 hours.
Renal adjustment
Caution in severe renal impairment. Paracetamol clearance is reduced. Phenylephrine excretion is renal. Dose reduction may be required, particularly for paracetamol, based on creatinine clearance. Avoid if CrCl <10 mL/min for paracetamol components without close monitoring. Consult nephrologist for precise guidance in severe cases.…

Pharmacokinetics

Onset
Paracetamol: 30-60 minutes; Caffeine: 30-60 minutes; Phenylephrine: 15-20 minutes (oral)
Peak effect
Paracetamol: 1-2 hours; Caffeine: 30-120 minutes; Phenylephrine: 1-2 hours
Protein binding
Paracetamol: 10-25%; Caffeine: 15-35%; Phenylephrine: Low (<50%)

Contraindications

  • Hypersensitivity to any component
  • Severe hypertension
  • Coronary artery disease
  • Patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy
  • Hyperthyroidism
  • Severe hepatic or renal impairment
  • Angle-closure glaucoma
  • Prostatic hypertrophy
  • Diabetes mellitus (uncontrolled)

Side effects

Common
NauseaDizzinessInsomniaRestlessnessHeadachePalpitationsDry mouthMild gastrointestinal upsetNervousness
Serious
  • Severe allergic reactions (e.g., anaphylaxis, angioedema)
  • Hepatotoxicity (especially with paracetamol overdose)
  • Stevens-Johnson Syndrome (SJS)
  • Toxic Epidermal Necrolysis (TEN)
  • Severe hypertension
  • Tachycardia
  • Arrhythmias
  • Anxiety
  • Hallucinations
  • Acute renal failure (rare, in overdose or with pre-existing conditions)
  • Add "Reflex bradycardia"
  • Add "Atrophic rhinitis, Anosmia (with prolonged use)"
  • Add "Increased risk of severe hypertension, especially in patients with pre-existing hypertension or those concurrently taking MAO inhibitors."

Pregnancy & lactation

Pregnancy

Category C (Phenylephrine is Category C; Paracetamol is Category B; Caffeine is Category B or C depending on dose and source). Overall, the combination is generally considered Category C due to Phenylephrine. Use only if the potential benefit justifies the potential risk to the fetus.

Lactation

Paracetamol is generally considered safe during lactation. Caffeine is excreted into breast milk and can cause irritability or sleep disturbances in breastfed infants; use with caution. Phenylephrine can pass into breast milk and may potentially reduce milk supply, especially with prolonged use. It should be used with caution during breastfeeding, and infant monitoring for irritability or sleep issues is advised. Avoid prolonged or high-dose use.

Drug interactions

Sulfasalazine
Contraindicated
Textbook

Exacerbation of inflammatory bowel disease (IBD).

Avoid combining sulfasalazine with traditional NSAIDs.

Source: G&G 14e · p1112

Aminoglycoside
Severe
Textbook

Increased risk of nephrotoxicity.

Avoid concurrent use.

Source: KDT 7e · p746

Aminoglycosides
Severe
Textbook

Increased aminoglycoside levels and potential toxicity.

Monitor aminoglycoside levels and renal function; adjust dosage as needed.

Source: KDT 7e

Anticoagulants
Severe
Textbook

Increased risk of gastrointestinal bleed.

Monitor for bleeding; consider alternative analgesics or gastroprotective agents.

Source: KDT 7e

Ciprofloxacin
Severe
Textbook

Enhanced CNS toxicity, seizures reported.

Source: KDT 7e

Citalopram
Severe
Textbook

Increased risk of gastrointestinal bleed.

Monitor for bleeding; consider gastroprotective agents or alternative analgesics.

Source: KDT 7e

Clopidogrel
Severe
Textbook

Increased bleeding risk.

Exercise extra caution and monitor for signs of bleeding.

Source: G&G 14e

Corticosteroids
Severe
Textbook

Increased risk of gastrointestinal bleed.

Monitor for bleeding; consider gastroprotective agents.

Source: KDT 7e

Cyclosporine
Severe
Textbook

Increased nephrotoxicity.

Avoid concomitant use or monitor renal function closely.

Source: KDT 7e

Dapoxetine
Severe
Textbook

Increased risk of gastrointestinal bleed.

Monitor for bleeding; consider gastroprotective agents or alternative analgesics.

Source: KDT 7e

Enalaprilat
Severe
Textbook

Reduced effectiveness of ACE inhibitors. Marked hyperkalemia, potentially leading to cardiac arrhythmia.

Use with caution, especially in the elderly and in patients with hypertension, diabetes mellitus, or ischemic heart disease.

Source: G&G 14e · p836

Escitalopram + Clonazepam
Severe
Textbook

Increased risk of gastrointestinal bleed.

Monitor for bleeding; consider gastroprotective agents or alternative analgesics.

Source: KDT 7e

Related guidelines

Other NSAID drugs

Ask House about Paracetamol + Caffeine + Phenylephrine

Continue into a citation-backed clinical answer with the drug context already attached.